Biota has just got approval in Japan for Laninamivir. This the main product to replace Relenza as patents expire over the next 4-9 years.
Hoping a ROW licensing deal can now be done for the product at a good price.
I hold.
- Forums
- ASX - General
- looking for aus pharmaceuticals to invest in
looking for aus pharmaceuticals to invest in, page-43
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)